This article is more than 5 years old. Information may no longer be current.

AcuFocus submits premarket approval application for corneal inlay

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Subscribe

Added to email alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

AcuFocus has completed submission of its premarket approval application to the U.S. Food and Drug Administration for the Kamra corneal inlay, according to a news release.

The device has a 1.6-mm aperture to allow only focused light to enter the eye, improving near and intermediate vision without reducing distance vision, the release said.

The inlay is approved in 47 countries and has been implanted almost 20,000 times. It is the first corneal inlay for presbyopia treatment submitted to the FDA.